Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Cases of kidney Stone Disorders
4.2.2 Rise in Demand for Minimally Invasive Surgeries
4.2.3 Technological Advancements in Nephrostomy Devices
4.3 Market Restraints
4.3.1 Alternative Procedures Such as Ureteral Stenting
4.3.2 Risk Associated with Nephrostomy Procedure
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Drainage Tubes
5.1.2 Dilators Sheaths
5.1.3 Guidewires
5.1.4 Nephrostomy Catheters
5.1.5 Other Products
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Teleflex Incorporated
6.1.3 Cardinal Health
6.1.4 Becton, Dickinson and Company
6.1.5 B. Braun Melsungen AG
6.1.6 Cook Medical Incorporated
6.1.7 Coloplast Group
6.1.8 Argon Medical
6.1.9 Angiodynamics Inc
6.1.10 Envaste Limited


7 MARKET OPPORTUNITIES AND FUTURE TRENDS